Dr. Brad Rodu discuss the new study on smokeless tobacco products and the effect it has on the human body.

Brad Rodu is a Senior Fellow of the Heartland Institute and holds the Endowed Chair in Tobacco Harm Reduction Research at the University of Louisville’s James Graham Brown Cancer Center.

Rodu’s research focuses on the substitution of safer tobacco products by smokers who are unable or unwilling to quit smoking with conventional cessation methods because of their addiction to nicotine. His research in comparative epidemiology established the scientific foundation for harm reduction and he continues to study clinical and social interventions aimed at harm reduction.

Prior to taking on his current position at U of L, Rodu served on the faculty of the University of Alabama at Birmingham. He earned his D.D.S. at the Ohio State University, completed a residency in oral pathology at Emory University in Atlanta, and was awarded NCI and ACS fellowships at UAB.

 

www.buildgrowandenjoy.com